Millipore Sigma Vibrant Logo

69753 pET-25b(+) DNA - Novagen

69753
Preis & Verfügbarkeit

Übersicht

Replacement Information

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
69753-3
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 10 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewThe pET-25b(+) vector carries an N-terminal pelB signal sequence for potential periplasmic localization, plus optional C-terminal HSV•Tag® and His•Tag® sequence. Note that the sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the vector map (TB065).

      The pET Vectors are supplied as purified plasmid DNA (10 µg). Each order of pET DNA also includes an Induction Control strain (supplied as a glycerol stock). Please contact technical service if you need additional information.




      This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@milliporesigma.com.
      This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
      Catalogue Number69753
      Brand Family Novagen®
      References
      Product Information
      Quality LevelMQ100
      Applications
      Biological Information
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      69753-3 04055977258899

      Documentation

      pET-25b(+) DNA - Novagen Analysenzertifikate

      TitelChargennummer
      69753

      Literaturstellen

      Titel
    • Gene L. Bidwell and Drazen Raucher. 2005. Molecular Cancer Therapeutics 4, 1076.
    • Nikola Kostlánová, et al. 2005. Journal of Biological Chemistry 280, 27839.
    • Zhou, H., et al. 2005. Journal of Biological Chemistry 280, 11303.
    • Trabbic-Carlson, K., et al. 2004.Protein Engineering Design and Selection 17, 57.
    • Deckert, P.M., et al. 2003. British Journal of Cancer 88, 937.
    • Songmin Cai and John H. Exton. 2001. Biochemical Journal 355, 779.
    • Kerri Cooper and Francois Baneyx. 2001. Protein Expression and Purification 21, 323.
    • West, M.W., et al. 1999. Procedings of the National Academy of Science 96, 11211.
    • L.L. Murley and N.D.F. Grindley. 1998. Cell 95, 553.
    • Zhou, P., et al. 1998. Journal of Immunology 160, 1439.
    • Anwendungsvorschriften

      Titel
      TB053 Academic and Non-profit Laboratory Assurance Letter
      TB055 pET System Manual

      Vektor-Karte

      Titel
      TB065 pET-25b(+) Vector Map

      Verwandte Produkte & Anwendungen

      Related Products

      Kategorien

      Life Science Research > Genomic Analysis > Transfection and Protein Expression > Bacterial Expression > Bacterial Expression Vectors